## IT: Gartner, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 0.2% below STRENGTH zone (3.0-6.0%); PEG 1.99 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($240.16)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 1, Bearish: 2)

**1. Highland Capital Management LLC Makes New Investment in Gartner, Inc. $IT**
- Source: MarketBeat | 20251227T114953 | Neutral | Relevance: 100%
- Highland Capital Management LLC recently initiated a new position in Gartner, Inc. (NYSE: IT) during Q3, acquiring 5,715 shares valued at approximately $1.50 million. This investment contributes to institutional investors collectively owning about 91.5% of Gartner's stock. The article also highlights a significant insider purchase by Director Stephen G. Pagliuca and a mixed outlook from analysts, with a consensus "Hold" rating despite Gartner beating Q3 EPS estimates.

**2. ZeOmega Recognized in 2025 Gartner(R) Market Guide for U.S. Healthcare Payer Care Management Workflow Applications**
- Source: Shreveport Times | 20251227T070847 | Somewhat-Bullish | Relevance: 100%
- ZeOmega has been recognized as a "Visionary Incumbent" in the 2025 Gartner Market Guide for U.S. Healthcare Payer Care Management Workflow Applications, a recognition they believe highlights their efforts to modernize payer care management amid evolving regulatory and technological demands. The company's Jiva Population Health Enterprise Management Platform addresses critical needs in healthcare by leveraging AI and analytics to automate workflows, identify at-risk populations, facilitate data exchange, and enhance member engagement. This acknowledgment affirms ZeOmega's commitment to providing advanced solutions that help health plans adapt to shifting policies, clinical standards, and member expectations, ultimately driving better outcomes.

**3. Voya Investment Management LLC Decreases Stake in Gartner, Inc. $IT**
- Source: MarketBeat | 20251226T131551 | Somewhat-Bearish | Relevance: 100%
- Voya Investment Management LLC significantly reduced its stake in Gartner, Inc. (NYSE:IT) by 62.1% in the third quarter, selling 29,315 shares and retaining 17,923 shares valued at approximately $4.71 million. Despite this, Gartner exceeded Q3 EPS estimates and set FY2025 EPS guidance in line with expectations. The stock currently holds a "Hold" consensus rating from analysts, with substantial institutional ownership.

**4. Gartner (IT) Fell Following Weak Results**
- Source: Insider Monkey | 20251225T085900 | Bearish | Relevance: 100%
- Gartner, Inc. (NYSE: IT) shares dropped after reporting disappointing quarterly results despite topping consensus estimates, due to decelerating growth outside the U.S. Federal business and lowered forward guidance. TCW Concentrated Large Cap Growth Fund, which held a position in Gartner, fully exited the stock due to concerns about AI's impact on Gartner's business model and total addressable market. The company's revenue increased 3% year-over-year to $1.5 billion in Q3 2025, but hedge fund interest in Gartner also declined.

**5. Gartner debuts 4PL Magic Quadrant as tariffs and disruption reshape logistics**
- Source: FreightWaves | 20251224T040853 | Bullish | Relevance: 100%
- Gartner has launched its first Magic Quadrant for Fourth-Party Logistics (4PL), defining the segment as orchestrators responsible for end-to-end visibility and optimization in increasingly complex global supply chains. The report highlights companies like Unilog and Redwood Logistics that excel in disruption management, leveraging asset-light models and deep technology integrations to address persistent tariffs and geopolitical risks. The debut signifies a shift toward advanced supply chain orchestration, where 4PLs own and solve problems rather than merely reporting them.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $275 | $281 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 15 ($2.43M) |
| Sells | 7 ($0.21M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 1 |

**Top Holders:**
- Vanguard Group Inc: 14.0% (+5.3%)
- Blackrock Inc.: 10.6% (+0.5%)
- BAMCO Inc.: 6.0% (+18.3%)
- State Street Corpora: 4.9% (+2.8%)
- Independent Franchis: 4.4% (+100.0%)

### Key Risks

1. Elevated short interest (8.6%): bears positioning against stock.
2. Long-term trend broken: trading 22.2% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.99 elevated, pricing in significant growth expectations. Forward P/E 18.8x stretched relative to 5% growth. Quality metrics strong (ROE 109%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($2.4M), management confidence. Institutional flow bullish (9 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.1B |
| Beta | 1.08 |
| 52W Range | $222.54 - $584.01 |
| Short Interest | 8.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.99 |
| Forward P/E | 18.8 |
| Current P/E | 19.7 |
| YoY Growth | 5.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 4.3% to 0.2% (-4.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.8pp (needs >3.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Below SMA200 (0.78x), long-term trend not supportive. MACD histogram positive (1.87), confirming momentum. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.21% (CS: 78) | Neutral |
| RSI_14 | 67.2 | Neutral |
| MACD Histogram | 1.87 | Bullish |
| vs SMA20 | 1.054x | Above |
| vs SMA50 | 1.059x | Above |
| vs SMA200 | 0.778x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $252.52
- **Stop Loss:** $240.16 (4.9% risk)
- **Target:** $264.88 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 88
- **Position Value:** $22,221.76
- **Portfolio %:** 22.22%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-10 (Est: $3.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.43 | $2.76 | +13.7% |
| 2025Q2 | $3.31 | $3.53 | +6.8% |
| 2025Q1 | $2.72 | $2.98 | +9.7% |
| 2024Q4 | $3.26 | $5.45 | +67.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*